Full Programme - RHD Congress

Skip to content

THURSDAY, 2 NOVEMBER

FRIDAY, 3 NOVEMBER

SATURDAY, 4 NOVEMBER

THURSDAY, 2 NOVEMBER

	Strep A Vaccines	Pathogenesis & Other Biological Insights	Clinical Presentation & Contemporary Management	Tertiary Care & Surgery
9:00 – 10:30	Opening Plenary A Global Movement to End RHD Yas Grand 1,2,3 A Global Movement to End Rheumatic Heart Disease Thursday, 2 November Start time: 9:00 am End time: 10:30 am Yas Grand 1,2,3 Chair(s) Jagat Narula World Heart Federation Liesl Zühlke South African Medical Research Council Welcome remarks: Tedros Adhanom Ghebreyesus World Health Organization Presentations Fighting RHD in the WHO Eastern Mediterranean Region (EMR) – The Challenge, the Response and the Way Forward Asmus Hammerich (WHO EMRO) A Vision to End RHD: Hopes for the WHA Resolution on RF and RHD Oyere Onuma (Massachusetts General Hospital) The Key Role of People Living with Rheumatic Heart Disease Amy Verstappen (Global ARCH) Eliminating RHD by 2050: How Many Lives Could Be Saved, and How Much Would It Cost? David Watkins (University of Washington)
10:30 – 11:15	Break / Poster Sessions Poster Sessions 1-2 Thursday, 2 November Start time: 10:30 am End time: 11:10 am E-Poster Area POSTER SESSION 1 (10:30-10:50) Station 1: Beneficial Effect Of Resveratrol To Inhibit Pathological Myofibroblast Differentiation Of Valvular Interstitial Cell In Experimental Heart Valve Model Station 2: Adherence To Benzathine Prophylaxis Among Rheumatic Fever And Rheumatic Heart Disease Patients Attending An Outpatient Clinic At Lira Regional Referral Hospital, Uganda Station 3: Immune System Activation In Rheumatic Heart Disease Station 4: Improvised Tricuspid Annuloplasty During Left-Side Valve Surgery Caused By Rheumatic Heart Disease Station 5: Doctors With Borders: The Impact Of International Travel Bans On Timorese Citizens Awaiting Cardiac Intervention Station 6: Echocardiographic Profile Of Children With Rheumatic Heart Disease At Tertiary Cardiac Center Of Nepal Station 7: Echocardiographic Screening For Rheumatic Heart Disease In Rural Cameroonian School Children Station 8: A Snowball Approach For Screening Of Asymptomatic Rheumatic Heart Disease Among School Age Children In Ethiopia: A Comparative Cross-Sectional Study Station 9: Rheumatic Heart Disease And Echo-Based Screening: A Four-Year Audit Of Suva School Program From 2018-2021 Station 10: Factors Associated With Severity Of Rheumatic Heart Disease Among Patients In Moi Teaching And Referral Hospital, Kenya, 2020 Station 12: Mean Level Of B-Type Natriuretic Peptide (BNP) In Patients With Mitral Stenosis Caused By Rheumatic Heart Disease Station 13: Use Of Alternative Drugs For Rheumatic Fever Prophylaxis In Place Of Injection Benzathine Penicillin Station 14: Investigating Benzathine Penicillin Prophylaxis In Rheumatic Heart Disease Mortality: A Verbal Autopsy Study POSTER SESSION 2 (10:50-11:10) Station 1: Rheumatic Heart Disease (RHD) Burden In Australia: Results And Learnings From Use Of Person-Linked Multi-Jurisdictional Data Station 2: Preoperative Left Ventricular Dysfunction Is A Risk Factor For Late Death In Paediatric Patients After Rheumatic Heart Disease Surgery For Isolated Aortic Valve Disease Station 3: Rapid Molecular Point-Of-Care Test For Strep A Pharyngitis In Remote-Living School Aged Children Station 4: The Gap Between Knowledge And Action: Understanding Community Behaviour Around Management Of Pediatric Sore Throats In Uganda Station 5: A Health Technology Landscape Assessment For A Novel M-Health Approach For Managing Rheumatic Heart Disease: Lessons From The Act Application Station 6: The Gap Between Knowledge And Action: Understanding Frontline Health Care Provider Management Practices Of Pediatric Sore Throats In Uganda Station 7: Assessment Of Improvement In Left Atrial Volume Index After Percutaneous Transvenous Mitral Commissurotomy Station 8: Serum FCN-3 Protein As A Potential Biomarker In Assessing Rheumatic Heart Disease Station 9: Oral Anticoagulation For Atrial Fibrillation In Rheumatic Heart Disease Station 10: Prevalence And Predictors Of Outcome In Patients With Predominant Rheumatic Mitral Stenosis In Eastern Nepal Station 11: End-User Experience Of The 2012 Whf Echocardiographic Criteria For Diagnosis Of Rheumatic Heart Disease – A Global Survey Station 12: Insights Into The Mechanisms Of Left Ventricular Dysfunction Through Assessment Of Diastolic Flow In Patients With Mitral Stenosis Using 3D Echocardiography Station 13: Circulating Serum Levels Of Group A Streptococcal Antibodies In RHD
10:30 – 11:15
11:15 – 12:15	Symposia
11:15 – 12:15	Identifying and Developing Strep A Vaccine Candidates Yas Grand 4 Identifying and Developing Strep A Vaccine Candidates Thursday, 2 November Start time: 11:15 am End time: 12:15 pm Yas Grand 4 Track: Strep A Vaccines Chair(s) Emmy Okello Uganda Heart Institute Luiza Guilherme Univeristy of São Paulo Presentations The Landscape of Vaccine Candidates Andrew Steer (Murdoch Children’s Research Institute) SAVAC Jerome Kim (International Vaccine Institute) ASAVI Alma Fulurija (University of Western Australia, Telethon Kids Institute)	Molecular Epidemiology of Strep Infection: Insights to Better Tackle Rheumatic Heart Disease Yas Grand 5 Molecular Epidemiology of Strep Infection: Insights to Better Tackle Rheumatic Heart Disease Thursday, 2 November Start time: 11:15 am End time: 12:15 pm Yas Grand 5 Track: Pathogenesis & Other Biological Insights Chair(s) Nikki Moreland University of Auckland Presentations The rheumatogenic emm-type concept in the light of global epidemiological data Josh Osowicki (Murdoch Children’s Research Institute) Studies on transmission in endemic regions Joselyn Rwebembera (Uganda Heart Institute) Whole genome sequencing of Strep A: Informing regional transmission pathways through longitudinal genomic epidemiology Mark Davies (University of Melbourne)	Housing, Environment, and Health: New, Novel, and Next in Primordial Prevention Yas Grand 1,2,3 Housing, Environment, and Health: New, Novel, and Next in Primordial Prevention Thursday, 2 November Start time: 11:15 am End time: 12:15 pm Yas Grand 1,2,3 Track: Clinical Presentation & Contemporary Management Chair(s) Maylene Shung-King University of Cape Town Liesl Zühlke University of Cape Town Presentations State of the Science and Strength of the Evidence, Patient Voice. Implementation, Dissemination, Cost. Moving past ‘a disease of poverty’ to understand specific environmental risk factors for ARF and RHD development Rosemary Wyber (Telethon Kids Institute) Understanding GAS transmission pathways and opportunities to intervene. Modern insights into the pathogenesis, epidemiology, and control of GAS infections Shiranee Sriskandan (Imperial College London) How much progress have we made? Novel insights into the design and implementation of primordial prevention strategies Anna Ralph (Menzies School of Health Research) Remote community laundries – A shared vision for improved health and social impact Le Smith (Heart Foundation of Australia) Elizabeth Morgan-Brett (Aboriginal Investment Group)	Improving Access to Catheter-Based Therapies Yas Stada 1,2 Improving Access to Catheter-Based Therapies Thursday, 2 November Start time: 11:15 am End time: 12:15 pm Yas Stada 1,2 Track: Tertiary Care & Surgery Chair(s) Ganesan Karthikeyan All India Institute of Medical Sciences Sajidah Khan University of Kwazulu-Natal Presentations Access to catheter-based therapies for RHD, capacity building and training for catheter therapies in LMICs (Magdi Yacoub lecture for advances in surgery for RHD) Krishna Kumar (Amrita Institute of Medical Sciences and Research Centre) Cost effectiveness: Aggressive preventive measures to surgical vs catheter based interventions Craig Sable (Children’s National Hospital in Washington, D.C)
12:15 – 13:30	Lunch & Poster Tour Clinical Presentation and Contemporary Management Poster Tour Thursday, 2 November Start time: 12:30 pm End time: 1:30 pm Station 1: Rheumatic Heart Disease In School Attending Nepalese Children: A Descriptive Analysis Of The National Heart Screening Database Station 2: High Rates Of Mortality In Uganda Following Acute Rheumatic Fever: A Community-Based Prospective Cohort Study Station 3: Building Towards Scale-Up Of Rheumatic Heart Disease Services In Uganda: The Adunu Program Station 4: Happy Heart Clinic. From Zero To Hero Station 5: Fiji Antenatal Echocardiography Screening (Fans) For Rheumatic Heart Disease By Trained Non-Expert Health Personnel Station 6: Primordial Prevention Of RHD: Research Priorities For Addressing The Social Determinants Of Health Chair(s) Andrea Beaton Cincinnati Children’s Hospital
12:15 – 13:30	LUNCH SYMPOSIUM - Sponsored by the Snow Foundation (12:15-13:15) How Philanthropy Can Support Collaborative Efforts to Progress Ending RHD Yas Grand 4 The Snow Foundation Symposium: How philanthropy can support collaborative efforts to progress ending RHD Thursday, 2 November Start time: 12:15 pm End time: 1:15 pm Yas Grand 4 Presentations Georgina Byron The Snow Foundation Vicki Wade Heart Foundation Australia Gavin Wheaton Women’s and Children’s Hospital Adelaide Bo Remenyi Royal Darwin Hospital Kenya McAdam Northern Territory Government of Australia Champions4Change Dawn Casey National Aboriginal Community Controlled Health Organisation Jonathan Carapetis Telethon Kids Institute
13:30 – 14:30	Symposia
13:30 – 14:30		Diagnostics and Biomarkers: How Far Along Are We? Yas Grand 5 Diagnostics and Biomarkers: How Far Along Are We? Thursday, 2 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 5 Track: Pathogenesis & Other Biological Insights Chair(s) Tom Parks Imperial College London Anna Norrby-Teglund Karolinska Institutet Presentations Biomarkers at the level of the valve Arun Bandyopadhyay (Gujarat Biotechnology University) The Potential of Antibody Biomarkers to Improve Rheumatic Fever Diagnosis Nikki Moreland (University of Auckland) Putting all in clinical context of Jones criteria and potential role of AI Andrea Beaton (Cincinnati Children’s Hospital)	Pragmatic Vs Perfect Primary Prevention Programmes Yas Grand 1,2,3 Pragmatic Vs Perfect Primary Prevention Programmes Thursday, 2 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 1,2,3 Track: Clinical Presentation & Contemporary Management Chair(s) Asha Bowen Perth Children’s Hospital Telethon Kids Institute Joselyn Rwebembera Uganda Heart Institute Presentations How do we address the issue of sub-clinical infections? (Edward Kaplan lecture for contribution to streptococcal biology) Ana Mocumbi (Universidade Eduardo Mondlane) Overview of Primary Prevention and the Dual Importance of Skin and Throat Infections Asha Bowen (Perth Children’s Hospital and Telethon Kids Institute) The Opportunity for Strep A Point-of-Care Testing to prevent ARF Bernadette Wong (Telethon Kids Institute) The Community Voice on Healthy Skin and Primary Prevention of ARF 2.5 Tracy McRae (University of Western Australia) Stephanie Enkel (University of Western Australia) What can we learn about primary prevention from SPYCATS? Edwin Armitage (London School of Hygiene and Tropical Medicine) Partnering with the community to support co-design of sore throat program Joselyn Rwebembera (Uganda Heart Institute)	Innovations in Cardiac Interventions Yas Stada 1,2 Innovations in Cardiac Interventions Thursday, 2 November Start time: 1:30 pm End time: 2:30 pm Yas Stada 1,2 Track: Tertiary Care & Surgery Chair(s) Geu-Ru Hong Yonsei University Emmy Okello Uganda Heart Institute Presentations Need for innovations in valve therapy Mpiko Ntsekhe (University of Cape Town) Evolving surgical techniques for rheumatic mitral valve disease Bhagawan Koirala (Manmohan Cardiothoracic Vascular and Transplant Center) Need for catheter registries in LMIC Krishna Kumar (Amrita Institute of Medical Sciences and Research Centre) Imaging-based Criteria for Identifying Suitable Candidates for Percutaneous Mitral Valvuloplasty Maria Do Carmo Nunes (Federal University of Minas Gerais)
14:30 – 15:15	Break / Poster Sessions Poster Sessions 3-4 Thursday, 2 November Start time: 2:30 pm End time: 3:10 pm POSTER SESSION 3 (14:30-14:50) Station 1: Follow-Up Echocardiographic Changes In Children And Youth Aged Less Than 25 Years With Latent Rheumatic Heart Disease: A Systematic Review And Meta-Analysis Of Global Data Station 2: A Comparison Of Sternal Precautions V/S Modified Sternal Precautions During Cardiac Rehabilitation Of Patients Following Median Sternotomy. A Randomised Pilot Controlled Trial Station 3: Prevention Of Rheumatic Heart Diseases In Zambia Station 4: Echocardiographic Assessment Of Mitral Valve By Wilkins Scoring To Determine The Outcome Of Percutaneous Mitral Balloon Valvuloplasty Station 5: Clinical Presentation, Echocardiographic Findings And Short Term Outcomes Of Children Admitted With Rheumatic Heart Disease In A Tertiary Care Hospital In Khartoum, Sudan. Station 6: A Blinded, Randomised Controlled Trial To Determine The Minimum Preventative Concentration Of Penicillin Required For Secondary Prophylaxis Of Rheumatic Heart Disease (The CHIPS Trial) Station 7: Trends In Rheumatic Heart Disease In Egypt (2006-2023): Data From The National Rheumatic Heart Prevention And Control Program Station 8: Effect Of Rheumatic Process On Myocardial Performance In Patients With Mild To Moderate Rheumatic Mitral Regurgitation: A Strain Study Station 9: Prevention, Control And Eradication Of Rheumatic Heart Disease (RHD) In Ghana, West Africa Echocardiographic Heart Screening Of 5000 School Children Station 10: Paroxysmal Atrial Fibrillation With Holter Ecg Monitoring In Patients With Severe Rheumatic Mitral Stenosis In Sinus Rhythm At Tikur Anbessa Specialized Hospital, Aau: Prospective Cross-Sectional Study Station 11: Developing A Strategy For Postoperative Tissue Valve Advocacy In A Low-Resource Setting Station 12: Population Health Impacts Of The Rheumatic Fever Strategy In Australia, 2010-2017 Station 13: Obstructive Coronary Artery Disease In Patients Undergoing Rheumatic Valvular Heart Surgery Station 14: Outcomes For School Children With Screening Detected Rheumatic Heart Disease In Timor-Leste Station 15: Absence Of Group A Streptococcus (Gas) In Children With Suspected Pharyngitis In A Highly Endemic Area In Maputo City During The Hot Season POSTER SESSION 4 (14:50-15:10) Station 1: Whole Genome Sequencing (WGS) To Determine The Resistome And Virulome Of GAS To Improve Management And Control Of RHD. Station 2: Molecular Epidemiology Of Superficial Streptococcus Pyogenes Infections In The Stop Trial, Western Australia Station 3: Treating Advanced Rheumatic Heart Disease: The Fifteen-Year Experience Of Salam Centre For Cardiac Surgery (Khartoum, Sudan) Station 4: Hindering Factors For Secondary Prophalaxis Among Rural Community In Sindh, Pakistan: A Cross-Sectional Study Station 5: Development Of The Active Community Case Management Tool (Act) – A Dynamic Application For Rheumatic Heart Disease Management Station 6: A Prospective Study On Adherence To Secondary Prophylaxis For Rheumatic Fever Using Benzathine Penicillin G In Mozambique Station 7: Clinical And Echocardiographic Outcomes In Rheumatic Heart Disease Patients With Supra-Systemic Pulmonary Hypertension: The Experience Of The Salam Centre For Cardiac Surgery Station 8: Mitral Valve Surgical Strategies For Patients In Haiti: Experiences And Outcomes Station 9: Profile Of Rheumatic Heart Disease At Cardiac Center In Medan City, Indonesia: Morbidity And Mortality Station 10: Changes In The Right Ventricular Global Longitudinal Strain After Balloon Mitral Valvuloplasty: A Comparison Between High Gradient Versus Low Gradient Very Severe Rheumatic Mitral Stenosis Station 11: Is There A Link Between Sociodemographic Factors And Rheumatic Heart Disease (Rhd) Severity: An Insight From Single-Center Rhd Registry Station 12: Explanation Of Pharmaceutical Care Of Cardiovascular Patients Hospitalized In Hospitals Affiliated With Shahid Beheshti University Of Medical Sciences Station 13: Unleashing The Factors Affecting The Outcome Of Pregnancy With Rheumatic Heart Disease: Evidence From Asian Population
14:30 – 15:15
15:15 – 16:15	Symposia
15:15 – 16:15	Technical Advances for Strep A Vaccine Development Yas Grand 4 Technical Advances for Strep A Vaccine Development Thursday, 2 November Start time: 3:15 pm End time: 4:15 pm Yas Grand 4 Track: Strep A Vaccines Chair(s) Jonathan Carapetis Telethon Kids Institute Presentations Development and validation of multiplexed electrochemiluminescent assays for the measurement of human immunoglobulin antibodies to group Strep antigens Alma Fulurija (University of Western Australia, Telethon Kids Institute) Characterization of a 5-plex assay to measure Streptococcus pyogenes IgA and IgG in oral fluid samples Fatoumata Camara (London School of Hygiene and Tropical Medicine) Systems serology identifies key correlates of Group A Streptococcus killing to inform vaccine development Reuben McGregor (University of Auckland) Adjuvant selection is critical to improve vaccine protection against GAS colonisation and invasive disease in animal models Tania Rivera-Hernandez (Cátedras Conacyt) Implementing Artificial Intelligence for Diagnosis of Rheumatic Disease: A Field Study Kelsey Brown (Children’s National Hospital in Washington, D.C)	Streptococcal Mechanisms: Novel Models and New Insights into Acute Rheumatic Fever and Rheumatic Heart Disease Yas Grand 5 Streptococcal Mechanisms: Novel Models and New Insights into Acute Rheumatic Fever and Rheumatic Heart Disease Thursday, 2 November Start time: 3:15 pm End time: 4:15 pm Yas Grand 5 Track: Pathogenesis & Other Biological Insights Chair(s) Tom Parks Imperial College London Najma Latif Imperial College London Presentations Establishment of a fully characterised model of Rheumatic Heart Disease Natkunam Ketheesan (University of New England) What can models teach us about host-pathogen interaction in rheumatic pathogenesis Shiranee Sriskandan (Imperial College, London) Prospects for ex-vivo models for rheumatic heart disease Najma Latif (Imperial College London)	Start Early and Aim High: Advances in Secondary Antibiotic Prophylaxis Yas Grand 1,2,3 Start Early and Aim High: Advances in Secondary Antibiotic Prophylaxis Thursday, 2 November Start time: 3:15 pm End time: 4:15 pm Yas Grand 1,2,3 Track: Clinical Presentation & Contemporary Management Chair(s) Sulafa Ali University of Khartoum Joseph Kado Telethon Kids Institute Presentations State of the Science and Strength of the Evidence: Patient Voice Vicki Wade (Heart Foundation of Australia) Journey on Penicillin Work Laurens Manning (University of Western Australia) Using pharmacokinetic modelling to understand and inform clinical trials for secondary prophylaxis of RHD Abdullah Al Shafi Majumder (Bangladesh Specialized Hospital Ltd) “Hurts Less, Lasts Longer”: Experiences of young people receiving high-dose subcutaneous infusions of benzathine penicillin G to prevent rheumatic heart disease Julie Bennett (University of Otago) Julie Cooper (University of Otago)	Risk Stratification Models for Valvular Surgery and Interventions Yas Stada 1,2 Risk Stratification Models for Valvular Surgery and Interventions Thursday, 2 November Start time: 3:15 pm End time: 4:15 pm Yas Stada 1,2 Track: Tertiary Care & Surgery Chair(s) Emmy Okello Uganda Heart Institute Presentations Surgical risk stratification for patients with RHD Krishna Kumar (Amrita Institute of Medical Sciences and Research Centre) Role of Heart Valve Team: Starting discussion with a case Geu-Ru Hong (Yonsei University) Preoperative Left Ventricular Dysfunction Is a Risk Factor for Late Death in Paediatric Patients after Rheumatic Heart Disease Surgery for Isolated Aortic Valve Disease Hilary Hardefeldt (Starship Children’s Hospital)
16:30 – 17:30	Opening Ceremony Yas Grand 1,2,3 Opening Ceremony Thursday, 2 November Start time: 4:30 pm End time: 5:30 pm Yas Grand 1,2,3 Chair(s) Daniel Pineiro World Heart Federation Jagat Narula World Heart Federation Jean-Luc Eisele World Heart Federation Liesl Zühlke University of Cape Town Dignitaries Welcome: Her.Excellency. Dr. Omniyat Mohamed Al Hajeri Kevin Rudd Former Prime Minister of Australia and Ambassador of Australia to the United States Community Health Division, Abu Dhabi Public Health Center Anu Gomanju NCDI Poverty Network Kathmandu Institute of Child Health Global ARCH

FRIDAY, 3 NOVEMBER

	Strep A Vaccines	Pathogenesis & Other Biological Insights	Clinical Presentation & Contemporary Management	Tertiary Care & Surgery
8:00 – 9:00	BREAKFAST SESSION - Sponsored by Edwards Foundation Every Heartbeat Matters: What More Can We Do to Impact Underserved RHD Patients? Yas Grand 4
9:00 – 10:30	Symposia
9:00 – 10:30	Equitable Access to Strep A Vaccines: From Testing to Implementation Yas Grand 4 Equitable Access to Strep A Vaccines: From Testing to Implementation Friday, 3 November Start time: 9:00 am End time: 10:30 am Yas Grand 4 Track: Strep A Vaccines Chair(s) Shiranee Sriskandan Imperial College London Presentations Animal and human challenge models Josh Osowicki (Murdoch Children’s Research Institute) Considerations for accelerating equitable access to Strep A vaccines globally Thomas Cherian (MMGH Consulting) Post-licensure studies Jerome Kim (International Vaccines Initiative) The Importance of Community Engaged Design for Clinical Trial Planning and Execution Andrea Beaton (Cincinnati Children’s Hospital)	Host-Focused Mechanisms Leading to Acute Rheumatic Fever and Rheumatic Heart Disease Yas Grand 5 Host-Focused Mechanisms Leading to Acute Rheumatic Fever and Rheumatic Heart Disease Friday, 3 November Start time: 9:00 am End time: 10:30 am Yas Grand 5 Track: Pathogenesis & Other Biological Insights Chair(s) Anna Norrby-Teglund Karolinska Institutet Presentations What do we know about molecular mimicry and RHD? Madeleine Cunningham (University of Oklahoma Health Sciences Center) Virulence potential of streptococcal M and M-like surface proteins Pierre Smeesters (Hôpital Universitaire des Enfants Reine Fabiola) Role of Group A carbohydrate and other glycans Nina van Sorge (Amsterdam UMC) RHD and host genetics Tom Parks (Imperial College London)	The Know-Do Gap: Implementing and Disseminating Best Practices Yas Grand 1,2,3 The Know-Do Gap: Implementing and Disseminating Best Practices Friday, 3 November Start time: 9:00 am End time: 10:30 am Yas Grand 1,2,3 Track: Clinical Presentation & Contemporary Management Chair(s) Sulafa Ali University of Khartoum Krishna Kumar Amrita Institute of Medical Sciences and Research Centre Presentations Keynote address (Padmavati – Roy – Bhatia – Tandon lecture for Global Influence in the Field of RHD): Liesl Zühlke University of Cape Town Emmy Okello Uganda Heart Institute Oyoo Charles Akiya Ministry of Health of Uganda Poonam Pal Ministry of Health and Medical Services of Fiji Management of severe rheumatic mitral and aortic regurgitation in the young Nigel Wilson (Starship Children’s Hospital)	More in Medical Therapies for Rheumatic Heart Disease Yas Stada 1,2 More in Medical Therapies for Rheumatic Heart Disease Friday, 3 November Start time: 9:00 am End time: 10:30 am Yas Stada 1,2 Track: Tertiary Care & Surgery Chair(s) Bo Remenyi Royal Darwin Hospital Presentations Anticoagulation for atrial fibrillation in RHD after INVICTUS (Bongani Mayosi lecture for leadership in clinical trials) Ganesan Karthikeyan (All India Institute of Medical Sciences) Medical management of heart failure Joselyn Rwebembera (Uganda Heart Institute) Care for RHD-affected young women Ana Mocumbi (Universidade Eduardo Mondlane) New Formulations Laurens Manning (University of Western Autralia) Novel therapeutics for ARF and RHD: Lessons from HCQ4ARF study Rachel Webb (University of Auckland)
10:30 – 11:15	Break / Poster Sessions Poster Sessions 5-6 Friday, 3 November Start time: 10:30 am End time: 11:10 am E-Poster Area POSTER SESSION 5 (10:30-10:50) Station 1: Iron Deficiency In Chronic Heart Failure Patients At The University Teaching Hospital In Lusaka, Zambia. Station 2: Early Outcomes Of Mitral Valve Replacement Performed By Residents On High Risk Patients At A Centre Serving Urban Poor Community. (A Single Centre Experience) Station 3: A Strategic Policy Of Capacity Building For The Definitive Treatment Of Advanced Rheumatic And Structural Heart Pathologies-35 Years Of Evidence, Impact And Lessons Learned In Underserved Nations Station 4: Rheumatic Heart Disease Education And Awareness In Nakivale Refugee Settlement, Uganda Station 6: Comparison Of Pain Scale Using Lidocaine As A Diluent Versus Lidocaine Plus Coughing Technique During Benzathine Penicillin G Administration In Pediatric Patients With Rheumatic Fever And Rheumatic Heart Disease Station 7: Integrating Task-Sharing For Rheumatic Heart Disease Screening: Realist Initial Program Theories Station 8: Acute Rheumatic Fever Presentations In South Auckland New Zealand 2020 – 2022 And Impact Of The Global Covid-19 Pandemic Station 9: Addressing Rheumatic Heart Disease In Fiji The Pacific Islands: A Paediatrician’s Perspective Of Challenges And The Way Forward. Station 10: Adherence To Benzathine Penicillin G Of Adolescents With Rheumatic Fever And Rheumatic Heart Disease In A Tertiary Hospital Station 11: Prevalence Of Rheumatic Heart Disease In Bali, Indonesia: A School-Based Echocardiographic Screening Station 12: The Echocardiographic Diagnosis Of Rheumatic Heart Disease: A Review Of The Performance And Application Of The World Heart Federation Criteria Station 13: Gene Expression Analysis Of Rheumatic Heart Disease Valves Using Nanostring Technology POSTER SESSION 6 (10:50-11:10) Station 1: Automated Two-Way Messaging Intervention To Support Secondary Prophylaxis Adherence In Rheumatic Heart Disease Station 2: Community Awareness On Rheumatic Heart Disease Training Workshop In Tanzania : A Prospective Observational Study Station 3: Reaching The Unreached: How The Mater Hospital In Kenya Is Bridging A Huge Gap In Rheumatic Fever (Rf) And Rheumatic Heart Disease (Rhd) Prevention, Diagnosis And Treatment Station 4: Health Care Provider-Led Education To Prevent Streptococcal Infections And The Risk Of Rheumatic Heart Disease: A Systematic Review Station 5: Technical Design Considerations For A Web Rhd Registry Application For Use In Low-Resource Settings Station 6: Mitraclip/Triclip Versus Pascal Implantation In Patients Undergoing Transcatheter Tricuspid Valve Replacement (Ttvr) For Tricuspid Regurgitation (Tr). Which System Is Preferred? A Pooled Meta-Analysis Of 2178 Patients Station 7: Health Related Quality Of Life Of Ugandan Children Following Valve Replacement Surgery For Rheumatic Heart Disease Station 8: Morbidity, Mortality And Survivorship Bias In Prevalent And Incidence Rheumatic Heart Disease: A Prospective Cohort Study Station 9: A Pilot Rheumatic Heart Disease Screening Program Using Portable, Handheld Echocardiography In Rivas, Nicaragua Station 10: Left Ventricle Myocardial Work Correlated With Functional Capacity In Severe Mitral Stenosis Patients Station 11: Clinical Profile, Treatment And Follow-Up Of Patients With Rheumatic Mitral Stenosis In A Tertiary Center In Tanzania Station 12: Diagnosis Of Acute Rheumatic Fever For Research And Surveillance: Lessons From Lahore Station 13:Perinatal Outcomes For Australian Women With Arf/Rhd: A Multi-Jurisdictional Population-Based Data Linkage Study
11:15 – 12:15	Plenary Priority Setting for Strep A Vaccines Yas Grand 1,2,3 Priority Setting for Strep A Vaccines Friday, 3 November Start time: 11:15 am End time: 12:15 pm Yas Grand 1,2,3 Chair(s) Liesl Zühlke University of Cape Town Jonathan Carapetis Telethon Kids Institute Presentations Strep A vaccines: the view from upstream (James Dale and Edwin Beachey lecture for contribution to vaccines research) Jonathan Carapetis (Telethon Kids Institute) Emmy Okello Uganda Heart Institute Thomas Cherian MMGH Consulting Jagat Narula World Heart Federation Erini Tokarua Cure Kids Elizabeth Gatumia Kenya-Heart Anshu Banerjee World Health Organization
12:15 – 13:30	Lunch & Poster Tour Tertiary Care and Surgery Poster Tour Friday, 3 November Start time: 12:30 pm End time: 1:30 pm E-Poster Area Station 1: Long-Term Outcomes Of Rheumatic Aortic Regurgitation After Percutaneous Transmitral Commissurotomy Station 2: Post-Operative Outcomes In Critically Ill Rheumatic Heart Disease Patients At The Salam Centre For Cardiac Surgery Khartoum (Sudan): A 5-Year Retrospective Analysis (2017-2022) Station 3: Durability And Safety Of Prosthetic Heart Valves In Patients With Rheumatic Heart Disease: A Retrospective Cohort Study Station 4: Risks Factors Associated With Mechanical Valves Thrombosis: The Experience Of Salam Centre For Cardiac Surgery Station 5: Left Atrial Compliance After Following Percutaneous Mitral Balloon Valvuloplasty Is An Independent Predictor Of Long-Term Cardiovascular Events Station 6: Progressive Deterioration In Clinical Outcome In Rhd (Influence Of Therapeutic Interventions) Chair(s) Dominique Vervoort University of Toronto
13:30 – 14:30	Symposia
13:30 – 14:30	Vaccines Safety Yas Grand 4 Vaccines Safety Friday, 3 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 4 Track: Strep A Vaccines Chair(s) Shiranee Sriskandan Imperial College London Presentations The importance of safety in Strep A: Key considerations Shiranee Sriskandan (Imperial College London) The risk-benefit balance in vaccine development from the perspective of people living with RHD Erini Tokarua (Cure Kids) Vaccines Hesitancy and Key Considerations for Development Katie Attwell (University of Western Australia) *Safety assessment pathways for Streptococcus pyogenes* vaccines – learning from history Andrew Steer (Murdoch Children’s Research Institute) A plasma protein biomarker for ARF** Emmy Okello (Uganda Heart Institute)	The Neglected Stage of a Neglected Disease: Insights and Innovations for Tackling Rheumatic Fever Yas Grand 5 The Neglected Stage of a Neglected Disease: Insights and Innovations for Tackling Rheumatic Fever Friday, 3 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 5 Track: Pathogenesis & Other Biological Insights Track: Clinical Presentation & Contemporary Management Chair(s) Jagat Narula World Heart Federation Presentations Basic Science: New ways of diagnosing RF Anna Ralph (Menzies School of Health Research) Clinical Research: Simplified criteria for RHD Bo Remenyi (Royal Darwin Hospital) Silent Acute Rheumatic Fever Revealed by Handheld Echocardiography Sulafa Ali (University of Khartoum) Clinical Decision-making for Heart Failure in RHD: ARF, Worsening Disease, or else? Anita Saxena (Pt. BD Sharma University of Health Sciences)		Community Action to Drive Access to Catheter and Surgery Yas Stada 1,2 Community Action to Drive Access to Catheter and Surgery Friday, 3 November Start time: 1:30 pm End time: 2:30 pm Yas Stada 1,2 Track: Tertiary Care & Surgery Chair(s) Ana Mocumbi Universidade Eduardo Mondlane Presentations Establishing Valvular Heart Disease Programs in Developing World: Why and How? Mohammad Abdelghani (Al-Azhar University) Improving Access to Cardiac Surgery for the Six Billion Without Dominique Vervoort (University of Toronto) Impact of Patient support groups on care Flavia Baturine Kamalembo (Uganda Heart Institute) Understanding the lived experience and its impact Anu Gomanju (NCDI Poverty Network, Kathmandu Institute of Child Health and Global ARCH)
14:30 – 15:15	Break / Poster Sessions Poster Sessions 7-8 Friday, 3 November Start time: 2:30 pm End time: 3:10 pm E-Poster Area POSTER SESSION 7 (14:30-14:50) Station 1: Rheumatic Mitral Repair In Nepal: Early Experience Station 2: Preventing A Future Crisis: Addressing Rheumatic Heart Disease In School Students In Noakhali District, Bangladesh Station 3: Valve Surgery In The Fight Against Rheumatic Heart Disease (Rhd) In Nigeria: Is Victory In Sight? Station 4: Modes Of Transmission And Attack Rates Of Group A Streptococcal Infection: A Systematic Review And Meta-Analysis Station 5: Rheumatic Heart Disease Patient Voices From The Pacific: A Mixed Methods Study From Fiji Station 6: Results Of A Novel Train The Trainer Model For Scaling Rhd Active Case Finding Station 7: Echocardiography Training Among Healthcare Providers In Rural Rwanda Station 8: Rheumatic Heart Disease In Mozambique: Results Of 21 Years Of Surgery Station 9: Prevalence Of Rheumatic Heart Diseases Among Children And Adolescents In Slum Settlements, In Rivers State Station 10: Clinical Profile And Intra-Hospital Outcomes Of Adults Admitted With Heart Failure Due To Chronic Rheumatic Valvular Heart Disease In Ilorin, North Central Nigeria. An Eight Year Hospital Registry Station 11: Clinical Profile And Echocardiography Features Of Patients With Rheumatic Heart Disease: Single-Centre Retrospective Study In Indonesia Station 12: A M-Protein Based Super Immunogen Provides Long-Term Immunogenicity And Protection Against Group A Streptococcus (Strepa) Upper Respiratory Tract Infections POSTER SESSION 8 (14:50-15:10) Station 1: Rationale And Design Of A Controlled Quasi-Experimental Study Testing The Efficacy Of A Rheumatic Heart Disease Education Program In Babati, Tanzania Station 2: Rwandan Nurses Save Lives: Rheumatic Heart Disease Station 3: Health-Related Quality Of Life And Healthcare Consultations Among Adult Patients Before And After Diagnosis With Rheumatic Heart Disease In Namibia Station 4: A Comparison Of Community Sensitization Approaches To Increase Health Seeking Behavior For Acute Rheumatic Fever In Uganda Station 5: Enhancing Tertiary Care And Surgery In Namibia: An Analysis Station 6: Outcomes Of Possible And Probable Rheumatic Fever: A Cohort Study Using Northern Australian Register Data, 2013-2019 Station 7: Latent RHD In West Africa (LATTE Study) Station 8: Women , Reproductive Health And Rheumatic Heart Disease In Namibia Station 9: Screening For Rheumatic Heart Disease In First Degree Relatives Of Rhd Patients In Nepal Station 10: Clinical And Echocardiographic Characteristics Of Patients Who Developed Adverse Events Station 11: Outcomes Of Aortic And Mitral Valve Replacement In Patients With Rheumatic Heart Disease Station 12: Reliability And Agreement Of Echocardiographic Measures Of Anterior Mitral Leaflet Thickness In Patients With Rheumatic Mitral Valve Disease Station 13: The Clinical Profile Of Rheumatic Heart Disease At A Tertiary Care Hospital In Indonesia: An Observational Study Station 14: Clinical And Socio-Demographic Profiles Of Rheumatic Heart Disease In Tertiary Hospital In Eastern Indonesia
15:15 – 16:15	Plenary Establishing Integrated National Rheumatic Heart Disease Programmes Yas Grand 1,2,3 Establishing Integrated National Rheumatic Heart Disease Programmes Friday, 3 November Start time: 3:15 pm End time: 4:15 pm Yas Grand 1,2,3 Chair(s) Liesl Zühlke University of Cape Town Oyere Onuma Massachusetts General Hospital Presentations Dawn Casey National Aboriginal Community Controlled Health Organisation Lorraine Anderson Kimberley Aboriginal Medical Services Ana Mocumbi Universidade Eduardo Mondlane Juliet Balderas Philippine Foundation for the Prevention and Control of Rheumatic Fever and Rheumatic Heart Disease Amy Sanyahumbi Texas Children’s Hospital Hicham El-Berri WHO Regional Office for the Eastern Mediterranean
16:15 – 17:30	Symposia
16:15 – 17:30	The Latest in Strep A Vaccine Development (Abstract Session) Yas Grand 4 The Latest in Strep A Vaccine Development Friday, 3 November Start time: 4:15 pm End time: 5:30 pm Yas Grand 4 Chair(s) Alma Fulurija University of Western Australia Telethon Kids Institute Presentations Back to the future: Lessons from early twentieth century scarlet fever outbreaks for modern vaccine development Josh Osowicki (Murdoch Children’s Research Institute) Development of a Peptide-based vaccine to prevent rheumatic heart disease Michael Good (Griffith University) Facilitating Strep A Vaccine Development for Aotearoa New Zealand Nikki Moreland (University of Auckland) Platform for the recombinant production of group A streptococcus gylcoconjugate vaccines Helge Dorfmuller (University of Dundee) *A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes* via IL-17, macrophages and neutrophils** Manisha Pandey (University of Griffith)	SPECIAL SESSION Voices of RHD: Learning from Lived Experiences Yas Grand 1,2,3 Voices of RHD: Learning from Lived Experience Friday, 3 November Start time: 4:15 pm End time: 5:30 pm Yas Grand 1,2,3 Chair(s) Vicki Wade Heart Foundation of Australia Anu Gomanju NCDI Poverty Network Kathmandu Institute of Child Health Global ARCH Presentations Subjective wellbeing among rheumatic heart disease patients at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: Observational cross-sectional study Henok Tadele (Addis Ababa University) Increasing knowledge and awareness for the prevention of rheumatic fever and rheumatic heart disease through school-based education activities in an endemic country Keila Jamal (Mozambique Institute for Health Education and Research) Rheumatic heart disease patient voices from the Pacific: A mixed methods study from Fiji Jyotishna Mani (Cure Kids) Anticoagulation management of postoperative rheumatic heart disease patients in Rwanda Nicole Schulick (University of Colorado) Kenya McAdam Champions4Change Henrique Thomas Champions4Change Flavia Baturine Kamalembo Uganda Heart Institute Erini Tokarua Cure Kids	Is Digital Health the Future? Innovations and Opportunities in Rheumatic Heart Disease Yas Stada 1,2 Is Digital Health the Future? Innovations and Opportunities in Rheumatic Heart Disease Friday, 3 November Start time: 4:15 pm End time: 5:30 pm Yas Stada 1,2 Track: Clinical Presentation & Contemporary Management Track: Tertiary Care & Surgery Chair(s) Andrea Beaton Cincinnati Children’s Hospital Presentations Mobile RHD Registries Emmy Okello (Uganda Heart Institute) The Potential of Digital Technology and AI for the Rapid Diagnosis of GAS Pharyngitis Joselyn Rwebembera (Uganda Heart Institute) Opportunities and challenges in imaging for RHD Maria Do Carmo Nunes (Federal University of Minas Gerais) Delivering equitable and appropriate echocardiography in a multi-ethnic world Gillian Whalley (University of Otago)
17:45 - 19:00	FILM SCREENING 'Take Heart: Deadly Heart' Yas Grand 1,2,3

SATURDAY, 4 NOVEMBER

	Strep A Vaccines	Pathogenesis & Other Biological Insights	Clinical Presentation & Contemporary Management	Tertiary Care & Surgery
9:00 – 10:30	Plenary What Does Rheumatic Heart Disease Research Look Like in 10 Years’ Time? Yas Grand 1,2,3 Think Tank: What Does Rheumatic Heart Disease Research Look Like in 10 Years’ Time? Saturday, 4 November Start time: 9:00 am End time: 10:30 am Yas Grand 1,2,3 Chair(s) Jagat Narula World Heart Federation Shahryar Sheikh Doctors Hospital Lahore Presentations View from the inside: What are the current strengths and weaknesses of research in ARF and RHD? How do we make the most of the next decade? Mark Engel (South African Medical Research Council) View from the outside: How do we maximise the benefits of research for ARF and RHD patients? How do we make the most of the next decade? Anna Norrby-Teglund (Karolinska Institutet) Anna Ralph Menzies School of Health Research Tom Parks Imperial College London Emmy Okello Uganda Heart Institute Michael Baker University of Otago
10:30 – 11:15	Break / Poster Sessions Poster Sessions 9-10 Saturday, 4 November Start time: 10:30 am End time: 11:10 am E-Poster Area POSTER SESSION 9 (10:30-10:50) Station 1: Maternal And Fetal Outcomes Of Per Cutaneous Balloon Mitral Valvuloplasty In Rheumatic Heart Disease(Pbmv) During Pregnancy Station 2: Screening Detected Severe Rheumatic Heart Disease In Timor-Leste – Clinician’s Perspective From The Leno Besik Study Station 3: Establishing Decentralized Rheumatic Heart Disease Services In Uganda – The Add-Rhd Study: A Preliminary Report From The Field Station 4: Structured Psychotherapy Is Beneficial For Reducing Emotional Distress In Adults Patients With Chronic Rheumatic Valvular Heart Disease in Sub-Saharan Africa: A Case Report Station 5: Yarning With A Remote Aboriginal Community About The Future Of Skin Health Station 6: Severe Rhd From Antenatal Echocardiographic Screening Station 7: Access To Healthcare Services For People Living With Rheumatic Heart Disease (Plwrhd) In A Pandemic Environment In Fiji: Lessons From A Targeted Covid-19 Vaccination Drive Station 8: Integrating Echo Screening Into The School Health Nurse Visits In Primary Schools In Fiji Islands Station 9: Rhythm In Rheumatic Heart Disease Patients: Anticoagulation Strategy And 30 Days And 6 Months Outcomes Station 10: Left Atrial Strain Of Low Gradient Severe Mitral Stenosis Following Balloon Mitral Valvuloplasty Station 11: Association Of Left Atrial Strain Changes To Functional Capacity Changes In Mitral Stenosis Patients After Balloon Mitral Valvuloplasty Station 12: Mucosal Delivery Of Group A Streptococcus Vaccines Has Benefits Over Traditional Systemic Immunisation Station 13: Clinical Significance Of Microbiome Diversity Analysis In Subclinical And Clinical Rheumatic Heart Disease Among School Children In India: A Preliminary Report POSTER SESSION 10 (10:50-11:10) Station 1: A Partnership Of Clinical Excellence And Cultural Safety Station 2: Clinical Characteristics And Outcomes Of A Contemporary Cohort With Acute Rheumatic Fever From The Northeast Region Of Brazil Station 3: Deadly Heart Trek: Community-Consultation And Culture Driven Care Initiatives To Enhance Rheumatic Heart Disease Elimination In Remote & Regional Communities In Australia Station 4: A Case Report: Biological Mitral Valve Replacement In A 12 Year Old Girl Station 5: Hemodynamic Parameters Associated With Severe Rheumatic Mitral Stenosis With Low Transmitral Gradient Station 6: Acute Rheumatic Fever And Rheumatic Heart Disease In Children And Adolescents In Victoria, Australia Station 7: Adherence To Benzathine Penicillin G Secondary Prophylaxis And Its Determinants In Patients With Rheumatic Heart Disease At A Cardiac Center Of An Ethiopian Tertiary Care Teaching Hospital Station 8: Pattern Of Rheumatic Heart Disease Among Patients Attending At A Tertiary Care Hospital In Somalia: First Report From Somalia Station 9: Unraveling The Beat: Rbbb And The Wilkins Score In Mitral Stenosis Progression Station 10: Evaluation Of Diagnostic Score For Rheumatic Heart Disease (Dsr) To Assess Progression Of Subclinical Rhd At 7 Years Follow Up Station 11: Echocardiography Screening For Diagnosis Of Rheumatic Heart Disease By Nurses: A Diagnostic Accuracy Study In Nepal Station 12: The Role Of Biomarkers In Optimizing The Time Of Surgical Intervention In Rheumatic Aortic Stenosis
11:15 – 12:15	Plenary A Global Action Plan for Rheumatic Heart Disease Yas Grand 1,2,3 A Global Action Plan for Rheumatic Heart Disease Saturday, 4 November Start time: 11:15 am End time: 12:15 pm Yas Grand 1,2,3 Chair(s) Liesl Zühlke University of Cape Town Andrew Steer Murdoch Children’s Research Institute Presentations Emmy Okello Pan-African Society of Cardiology Ivor Benjamin American Heart Association Anu Gomanju NCDI Poverty Network Kathmandu Institute of Child Health Global ARCH Asha Bowen Perth Children’s Hospital Telethon Kids Institute David Milan Leducq Key considerations for the development of a Global Action Plan Anshu Banerjee (World Health Organization)
12:15 – 13:30	Lunch & Poster Tour Pathogenesis and Strep A Vaccines Poster Tour Saturday, 4 November Start time: 12:30 pm End time: 1:30 pm E-Poster Area Station 1: Rapid Molecular Testing Aids Timely Diagnosis Of Strep A Infection In New Zealand Children With Acute Rheumatic Fever Station 2: ECG evolution after hydroxychloroquine treatment in acute rheumatic fever – data from HYDRxARF Station 3: Humoral Immune Responses To Streptococcus Pyogenes Within A Household Cohort Study In The Gambia Station 4: Targeted Profiling Of The Oropharyngeal Microbiota In Patients With Severe Rheumatic Heart Disease: A Case-Control Study Station 5: In Vitro Model Of Valvular Fibrosis: Valve Interstitial Cells Of Oryctolagus Cuniculus Induced By Transforming Growth Factor- I1, Interleukin-1, Interleukin-6, And Tumor Necrosis Factor-I Station 6: Strep A Pharyngitis Rates In Children Living In Urban Australia Emerging After The COVID-19 Pandemic Chair(s) Tom Parks Imperial College London
13:30 – 14:30	Symposia
13:30 – 14:30	Measuring and communicating the value of Strep A vaccines Yas Grand 4 Measuring and communicating the value of Strep A vaccines Saturday, 4 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 4 Track: Strep A Vaccines Chair(s) Anshu Banerjee World Health Organization Maylene Shung-King University of Cape Town Presentations The value of vaccination from a health and healthcare perspective Jeffrey Cannon (Telethon Kids Institute) Building the case for biopharma industry investment in Strep A vaccine development Don Walkinshaw (Shift Health) Communicating the Value of Group A Streptococcus Vaccine Research and Development: Full Benefits and Innovation Daniel Tortorice (College of the Holy Cross)	The Epidemiology and Burden of RHD and Other Strep A Diseases: New Insights Yas Grand 5 The Epidemiology and Burden of RHD and Other Strep A Diseases: New Insights Saturday, 4 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 5 Track: Pathogenesis & Other Biological Insights Chair(s) Rosemary Wyber Telethon Kids Institute Presentations The global burden of RHD David Watkins (University of Washington) Epidemiology of bacterial skin infections in primary healthcare in Auckland, New Zealand Krishtika Mala (University of Otago) Prevalence of rheumatic heart disease in Senegalese school children: A clinical and echocardiographic screening Aliou Assane Ngaide (Cheikh Anta DIOP University of Dakar) The burden of RHD in India: An overview Rajesh Beniwal (Calendula Healthcare Ltd)	The Importance and Implications of Early Rheumatic Heart Disease Detection and Treatment Yas Grand 1,2,3 The Importance and Implications of Early Rheumatic Heart Disease Detection and Treatment Saturday, 4 November Start time: 1:30 pm End time: 2:30 pm Yas Grand 1,2,3 Track: Clinical Presentation & Contemporary Management Chair(s) Liesl Zühlke University of Cape Town Presentations The importance of publishing evidence-based guidelines (Gene Stollerman lecture for advances in research) Greg Lim (Nature Reviews Cardiology) All you need to know about the new 2023 World Heart Federation Guidelines for echocardiographic diagnosis of RHD Joselyn Rwebembera (Uganda Heart Institute) Updates in the role of secondary antibiotic prophylaxis in latent RHD Andrea Beaton (Cincinnati Children’s Hospital)
14:30 – 15:30	Closing Ceremony Call to Action on Ending RHD Yas Grand 1,2,3 Closing Ceremony: Call to Action on Ending RHD Saturday, 4 November Start time: 2:30 pm End time: 3:30 pm Yas Grand 1,2,3 Chair(s) Jagat Narula World Heart Federation Liesl Zühlke University of Cape Town Presentations Vaccines track action points Jonathan Carapetis (Telethon Kids Institute) Liesl Zühlke (University of Cape Town) Pathogenesis track action points Mark Engel (South African Medical Research Council) Clinical presentation and contemporary management track action points Sulafa Ali (University of Khartoum) Joe Kado (Telethon Kids Institute) Tertiary care and surgery track action points Emmy Okello (Uganda Heart Institute) Maria Do Carmo Nunes (Federal University of Minas Gerais) Translating the call to local action: reflections on Pakistan Shahryar Sheikh (World Heart Federation) Reflections and WHF call to action Jagat Narula (World Heart Federation) Official close Jean-Luc Eiselé (World Heart Federation)

worldheartfederation

Follow us on Instagram

worldheartfederation

2 May

It's been another successful #AnginaAwarenessMonth!Let's remember that this initiative is all about staying well—for as long as possible. So we can do the things we love, with the people we love.Learn about the symptoms of #angina and what you can do to stay well and active at the link in bio.

worldheartfederation

1 May

#Angina symptoms differ from person to person. That’s why it’s key to know what to look out for and what to mention to your doctor.USE ❤️ TO ACT NOW ON ANGINA.Learn more at the link in our bio.#AnginaAwarenessMonth #AnginaAwareness #ActNowOnAngina

worldheartfederation

26 Apr

For Joanne, the worst #angina is the one that knocks you on the floor with pain and squeezing in the chest. Her symptoms didn’t always match typical angina symptoms. Read more about her battle to get a diagnosis at the link in bio.#AnginaAwarenessMonth #UseHeart #ActNowOnAngina

worldheartfederation

25 Apr

🎙️ Tune in to our latest podcast episode featuring David Flood, as he dives deep into his motivation behind researching aspirin for secondary prevention in low- and middle-income countries.🎧 Listen to the #GlobalHeartPodcast at the link in bio.

worldheartfederation

24 Apr

Despite symptoms, one-quarter of angina cases go undiagnosed. This #AnginaAwarenessMonth, we’re out to change that. What could you do to get on top of angina symptoms for yourself and those you care about?Head to the link in our bio to find out. #angina #AnginaAwareness #UseHeart #ActNowOnAngina

worldheartfederation

23 Apr

Feeling your heart race more often or for extended periods of time could signal underlying health issues, such as heart rhythm problems (#arrhythmias) 💔 Don't ignore it—seek medical advice if you notice this happening frequently!

worldheartfederation

22 Apr

Today is #EarthDay.The climate crisis is a health crisis. It affects everyone in the 🌍🌏🌎 and increases our risk of cardiovascular disease by polluting the air that sustains our lives.Let's take care of our hearts and our planet.#UseHeart #BetterTomorrow #SaveThePlanet

worldheartfederation

19 Apr

120 million people have angina, but the symptoms can vary from person to person.Don’t let angina stop you from doing the things you love. Take a few minutes this #AnginaAwarenessMonth to learn about the key symptoms and what to do next.Find out more at the link in bio.

© World Heart Federation 2024